2CT-2-EtO

2CT-2-EtO, also known as 2-ethoxy-5-methoxy-4-methylthiophenethylamine, is a psychoactive drug of the phenethylamine, 2C, and TWEETIO families related to the psychedelic drug 2C-T.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

2CT-2-EtO, also known as 2-ethoxy-5-methoxy-4-methylthiophenethylamine, is a psychoactive drug of the phenethylamine, 2C, and TWEETIO families related to the psychedelic drug 2C-T. It is the derivative of 2C-T in which the methoxy group at the 2 position has been replaced with an ethoxy group. According to Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, 2CT-2-EtO's dose is 50 mg orally and its duration is 4 hours.

It is said to have a "very quick" onset. The effects of 2CT-2-EtO are said to be "mild", reaching no greater than a "plus-one" on the Shulgin Rating Scale, and were reported to include blurred vision, with no other specific effects described. Higher doses of the drug were not assessed.

The chemical synthesis of 2CT-2-EtO has been described. 2CT-2-EtO was first described in the literature by Shulgin in PiHKAL in 1991. It was developed and tested by Darrell Lemaire, with publication via personal communication with Shulgin.

The drug is a controlled substance in Canada under phenethylamine blanket-ban language.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1348040534 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

7 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.